Gene editing is starting to become truly "big business", according to this profile from New Yorker magazine. Patent litigation is ongoing to identify who owns the rights to the underlying technology. New Yorker , and venture-capital firms are investing more than a thousand to gain exposure to technology that has wide-ranging implications for not just human afflictions, but potentially crop blights and livestock disease too. The RNA that CRISPR relies upon to guide the molecular scalpel to its target is made of twenty base pairs. Many are worried about its repercussions, however, Professor of Chemistry and of New Yorker at Berkeley and pioneer of CRISPR researcher, Jennfier Doudna , has been particularly outspoken about the potential for harm. She has called for a research moratorium in September , following the publication of research from Berkeley , in which scientists used CRISPR to repair the gene responsible for betathalassemia.
Gene editing is starting to become truly "big business", according to this profile from New Yorker magazine. Patent litigation is ongoing to identify who owns the rights to the underlying technology. New Yorker , and venture-capital firms are investing more than a thousand to gain exposure to technology that has wide-ranging implications for not just human afflictions, but potentially crop blights and livestock disease too. Many are worried about its repercussions, however, Professor of Chemistry and of New Yorker at Berkeley and pioneer of CRISPR researcher, Jennfier Doudna , has been particularly outspoken about the potential for harm. She has called for a research moratorium in September , following the publication of research from Berkeley , in which scientists used CRISPR to repair the gene responsible for betathalassemia.